Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access pancreatic cancer specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic cancer treatment provided free
This is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients refractory to prior treatment of metastatic pancreatic cancer.
Sponsor: Cantex Pharmaceuticals
Check if you qualify for this pancreatic cancer clinical trial in Los Angeles, CA
If you're searching for pancreatic cancer treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.